Intervacc AB is a Swedish AB based in Hägersten, operating in the Veterinary activities sector. Incorporated in 1983, the company has 11 employees and reported revenue of SEK 10.6m in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva forskning och utveckling samt affärsverksamhet inom vaccinområdet och därmed förenlig verksamhet.
In its most recent annual report (2025), Intervacc AB reported revenue of SEK 10.6m, an increase of 278% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of SEK 80.6m, and the EBITDA margin stood at -588%.
At the end of 2025, equity financed 95% of the balance sheet, and current assets covered short-term debt 10.5 times.
Frequently asked questions
What is the Org number of Intervacc AB?
Intervacc AB is registered with Bolagsverket / SCB under Org 5562381748.
What is the revenue of Intervacc AB?
Intervacc AB reported revenue of SEK 10.6m in 2025.
How many employees does Intervacc AB have?
Intervacc AB employs 11 people as of the latest annual report.
Who is the CEO of Intervacc AB?
Carl Johan Dalsgaard is the CEO of Intervacc AB, in role since 2026.
Who is the chairman of Intervacc AB?
Emil Anders Billbäck chairs the board of Intervacc AB, in role since 2026.
Where is Intervacc AB headquartered?
Intervacc AB's registered address is Västertorpsvägen 135.
